MedTrace Logo

Assessment of Bmi-1 on Protein and Molecular Levels in Oral Dysplasia and Squamous Cell Carcinoma: A Diagnostic Study

NCT03345966 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2017-11-17

No results posted yet for this study

Summary

The aim of the current study is to assess the validation of Bmi-1 detection at both protein and molecular levels in oral epithelial dysplasia and oral squamous cell carcinoma as a biomarker for early cancer detection versus biopsy embedded in paraffin blocks.

Conditions

  • Oral Squamous Cell Carcinoma

Interventions

DIAGNOSTIC_TEST

Bmi-1 antibody

B-lymphoma Moloney murine leukemia virus insertion region-1

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Iman A. Radi, Professor · Cairo University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2018-12-31
Completion
2019-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03345966 on ClinicalTrials.gov